Cytokinetics Announces Initiation of Phase 1 Clinical Study of CK-3828136
Go back to Cytokinetics Announces Initiation of Phase 1 Clinical Study of CK-3828136| CYTOKINETICS (NASDAQ: CYTK) | Delayed: 71.40 --0 (-0%) | |||||
|---|---|---|---|---|---|---|
| Previous Close | $71.40 | 52 Week High | $13.18 | |||
| Open | $71.40 | 52 Week Low | $6.00 | |||
| Day High | $71.40 | P/E | N/A | |||
| Day Low | $71.40 | EPS | $-1.24 | |||
| Volume | 10,220 | |||||
